Suchergebnisse - "Alpan, Oral"

PubPharm (7)

1

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies

enthalten in: Frontiers in immunology | 2021

von Perez, E. | Hébert, J. | Ellis, A. | +6

2

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Schoepfer, A. | Hirano, I. | Coslovsky, M. | +61

3

A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

enthalten in: Pediatric rheumatology online journal | 2018

von Lovell, D. | Dare, J. | Francis-Sedlak, M. | +13

4

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis

enthalten in: Gastroenterology | 2016

von Safroneeva, E. | Straumann, A. | Coslovsky, M. | +60

CommentIn: Gastroenterology. 2016 Mar;150(3):547-9. - PMID 26812608

5

Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines : a randomized, placebo-controlled study

enthalten in: The Journal of investigative dermatology | 2015

von Saini, S. | Bindslev-Jensen, C. | Maurer, M. | +9

ErratumIn: J Invest Dermatol. 2015 Mar;135(3):925. - PMID 25501032

6

High eosinophil count : a potential biomarker for assessing successful omalizumab treatment effects

enthalten in: The Journal of allergy and clinical immunology | 2013

von Busse, W. | Spector, S. | Rosén, K. | +2

CommentIn: J Allergy Clin Immunol. 2014 Apr;133(4):1231. - PMID 24679472

7

Omalizumab in severe allergic asthma inadequately controlled with standard therapy : a randomized trial

enthalten in: Annals of internal medicine | 2011

von Hanania, N. | Alpan, O. | Hamilos, D. | +7

1
[1]